Illumina Inc (ILMN)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Illumina Inc (ILMN)
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Key Insights
Critical company metrics and information
Share Price
$141.09Market Cap
$22.38 BillionTotal Outstanding Shares
158.60 Million SharesTotal Employees
9,300Dividend
No dividendIPO Date
July 28, 2000SIC Description
Laboratory Analytical InstrumentsHomepage
https://www.illumina.com
Historical Stock Splits
If you bought 1 share of ILMN before September 23, 2008, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
September 23, 2008 | 2-for-1 |
Cash Flow Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities, Continuing | $-215.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-550.00 Million |
Net Cash Flow | $-58.00 Million |
Net Cash Flow From Operating Activities | $697.00 Million |
Net Cash Flow From Financing Activities | $-550.00 Million |
Net Cash Flow From Operating Activities, Continuing | $697.00 Million |
Net Cash Flow From Investing Activities | $-215.00 Million |
Exchange Gains/Losses | $10.00 Million |
Net Cash Flow, Continuing | $-68.00 Million |
Income Statement
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Net Income/Loss | $-1.59 Billion |
Benefits Costs and Expenses | $5.92 Billion |
Research and Development | $1.25 Billion |
Gross Profit | $2.81 Billion |
Cost Of Revenue | $1.58 Billion |
Basic Average Shares | $159.00 Million |
Diluted Earnings Per Share | $9.96 |
Nonoperating Income/Loss | $-361.00 Million |
Operating Expenses | $3.98 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $-1.59 Billion |
Basic Earnings Per Share | $9.95 |
Selling, General, and Administrative Expenses | $1.30 Billion |
Income/Loss From Continuing Operations After Tax | $-1.59 Billion |
Diluted Average Shares | $159.00 Million |
Costs And Expenses | $5.92 Billion |
Income Tax Expense/Benefit | $52.00 Million |
Other Operating Expenses | $1.43 Billion |
Income/Loss From Continuing Operations Before Tax | $-1.54 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Operating Income/Loss | $-1.17 Billion |
Net Income/Loss Attributable To Parent | $-1.59 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Revenues | $4.39 Billion |
Balance Sheet
September 30, 2023 to September 29, 2024
Metric | Value |
---|---|
Equity Attributable To Noncontrolling Interest | $0.00 |
Current Assets | $2.37 Billion |
Intangible Assets | $305.00 Million |
Assets | $6.01 Billion |
Liabilities | $3.89 Billion |
Wages | $237.00 Million |
Equity | $2.13 Billion |
Noncurrent Assets | $3.64 Billion |
Other Non-current Assets | $2.50 Billion |
Liabilities And Equity | $6.01 Billion |
Equity Attributable To Parent | $2.13 Billion |
Current Liabilities | $975.00 Million |
Accounts Payable | $191.00 Million |
Fixed Assets | $832.00 Million |
Noncurrent Liabilities | $2.91 Billion |
Other Current Liabilities | $547.00 Million |
Inventory | $574.00 Million |
Other Current Assets | $1.80 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.